Literature DB >> 26728501

Effects of modified constraint-induced movement therapy on the lower extremities in patients with stroke: a pilot study.

Yulian Zhu1,2, Chaosheng Zhou1,3, Yu Liu1, Jue Liu1, Jiaran Jin1, Shengnian Zhang1, Yulong Bai2, Dequan Huang4, Bing Zhu2, Yiming Xu2, Yi Wu2.   

Abstract

PURPOSE: This study aimed to qualify the improvements of modified constraint-induced movement therapy (m-CIMT) on the lower limb of stroke patients via assessing the centre of mass (COM) displacement and the basic gait parameters.
METHODS: A total of 22 hemiplegic patients after stroke with first-time clinical cerebral infarction or haemorrhagic cerebrovascular accident were included in this study from May to December, 2014. The patients were randomly divided into m-CIMT group and the conventional therapy group (control group), and received corresponding training for five days/week for four weeks. The COM displacement and gait parameters were assessed by three-dimensional segmental kinematics method in pre-intervention and post- intervention therapy.
RESULTS: After four weeks of m-CIMT, the COM displacement on sagittal plane of paretic leg during stance phase was increased (pre: 91.04 ± 4.39 cm, post: 92.38 ± 4.58 cm, p < 0.05) and swing range of frontal plane was remarkably decreased (pre: 10.15 ± 3.05 cm, post: 7.83 ± 1.90 cm, p < 0.001). Meantime, the normalised swing range of COM in m-CIMT was superior to that in control group. Moreover, the gait parameters, including velocity (0.27 m/s), step width (0.10 m), step length (0.22 m) and swing time percentage (29.80%), were significantly improved by post-interventions of m-CIMT (p < 0.05).
CONCLUSION: The m-CIMT intervention improves the COM displacement in sagittal and frontal plane, as well as gait parameters. These suggest that m-CIMT intervention may be feasible and effective for the rehabilitation of hemiplegic gait. Implications for Rehabilitation Segmental kinematics method was used to estimate the displacement of the COM. m-CIMT interventions improved the COM displacement of patients after stroke. m-CIMT interventions improved the hemiplegic gait parameters.

Entities:  

Keywords:  Centre of mass; constraint-induced movement therapy; gait; stroke

Mesh:

Year:  2016        PMID: 26728501     DOI: 10.3109/09638288.2015.1107775

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  5 in total

Review 1.  The Mechanism and Clinical Application of Constraint-Induced Movement Therapy in Stroke Rehabilitation.

Authors:  Dong Wang; Junlu Xiang; Ying He; Min Yuan; Li Dong; Zhenli Ye; Wei Mao
Journal:  Front Behav Neurosci       Date:  2022-06-21       Impact factor: 3.617

2.  Constraint-induced movement therapy in treatment of acute and sub-acute stroke: a meta-analysis of 16 randomized controlled trials.

Authors:  Xi-Hua Liu; Juan Huai; Jie Gao; Yang Zhang; Shou-Wei Yue
Journal:  Neural Regen Res       Date:  2017-09       Impact factor: 5.135

3.  Effects of Number of Repetitions and Number of Hours of Shaping Practice during Constraint-Induced Movement Therapy: A Randomized Controlled Trial.

Authors:  Auwal Abdullahi
Journal:  Neurol Res Int       Date:  2018-04-02

Review 4.  Impact of Constraint-Induced Movement Therapy (CIMT) on Functional Ambulation in Stroke Patients-A Systematic Review and Meta-Analysis.

Authors:  Ravi Shankar Reddy; Kumar Gular; Snehil Dixit; Praveen Kumar Kandakurti; Jaya Shanker Tedla; Ajay Prashad Gautam; Devika Rani Sangadala
Journal:  Int J Environ Res Public Health       Date:  2022-10-06       Impact factor: 4.614

Review 5.  Effectiveness of Constraint-Induced Movement Therapy (CIMT) on Balance and Functional Mobility in the Stroke Population: A Systematic Review and Meta-Analysis.

Authors:  Jaya Shanker Tedla; Kumar Gular; Ravi Shankar Reddy; Arthur de Sá Ferreira; Erika Carvalho Rodrigues; Venkata Nagaraj Kakaraparthi; Giles Gyer; Devika Rani Sangadala; Mohammed Qasheesh; Rakesh Krishna Kovela; Gopal Nambi
Journal:  Healthcare (Basel)       Date:  2022-03-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.